Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis.
Int J Mol Sci. 2023 Nov 29;24(23):16930. doi: 10.3390/ijms242316930.
Int J Mol Sci. 2023.
PMID: 38069251
Free PMC article.
Systemic Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Colon Cancer.
Iaciu CI, Emilescu RA, Cotan HT, Nitipir C.
Iaciu CI, et al. Among authors: cotan ht.
Chirurgia (Bucur). 2023 Jun;118(3):260-271. doi: 10.21614/chirurgia.2023.v.118.i.3.p.260.
Chirurgia (Bucur). 2023.
PMID: 37480352
Free article.
Item in Clipboard
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma.
Parosanu AI, Pirlog CF, Slavu CO, Stanciu IM, Cotan HT, Vrabie RC, Popa AM, Olaru M, Iaciu C, Bratu LI, Baicoianu IF, Moldoveanu O, Baston C, Nițipir C.
Parosanu AI, et al. Among authors: cotan ht.
Curr Oncol. 2023 Feb 17;30(2):2457-2464. doi: 10.3390/curroncol30020187.
Curr Oncol. 2023.
PMID: 36826148
Free PMC article.
Item in Clipboard
Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer.
Pirlog CF, Cotan HT, Parosanu A, Orlov Slavu C, Popa AM, Iaciu C, Olaru M, Oprita AV, Nita I, Nitipir C.
Pirlog CF, et al. Among authors: cotan ht.
Cureus. 2022 Jul 14;14(7):e26843. doi: 10.7759/cureus.26843. eCollection 2022 Jul.
Cureus. 2022.
PMID: 35974841
Free PMC article.
Item in Clipboard
Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?
Pîrlog CF, Costache R, Paroșanu AI, Slavu CO, Olaru M, Popa AM, Iaciu C, Niță I, Moțatu P, Cotan HT, Oprița AV, Costache D, Manolescu LSC, Nițipir C.
Pîrlog CF, et al. Among authors: cotan ht.
Diagnostics (Basel). 2023 May 29;13(11):1892. doi: 10.3390/diagnostics13111892.
Diagnostics (Basel). 2023.
PMID: 37296744
Free PMC article.
Item in Clipboard
Cite
Cite